Japan Research (15)
15 papers in the Japan topic, indexed by PF-Atlas from PubMed and global journals.
- Pamufetinib for chronic fibrosing interstitial lung diseases with a progressive phenotype: a double-blind, multicenter, phase 2b clinical trial. · American journal of respiratory and critical care medicine · 2026
- Predictive value of Eastern Cooperative Oncology Group performance status and body mass index for antifibrotic tolerability and prognosis in patients with idiopathic pulmonary fibrosis. · Respiratory medicine · 2025
- Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias. · Respiratory research · 2024
- Current challenges in the diagnosis and management of idiopathic pulmonary fibrosis in Japan. · Respiratory investigation · 2024
- [Aging-associated Cyst Formation and Fibrosis]. · Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan · 2024
- Real-World Clinical Efficacy of Antifibrotic Agents for Idiopathic Pulmonary Fibrosis: A Single-Center Retrospective Study in Japan. · Drugs - real world outcomes · 2024
- A Real-World Prognosis in Idiopathic Pulmonary Fibrosis: A Special Reference to the Role of Antifibrotic Agents for the Elderly. · Journal of clinical medicine · 2023
- Randomized phase II study of nintedanib with or without pirfenidone in patients with idiopathic pulmonary fibrosis who experienced disease progression during prior pirfenidone administration. · Medicine · 2022
- Evaluation of the potential complication of interstitial lung disease associated with antifibrotic drugs using data from databases reporting spontaneous adverse effects. · Clinical and translational science · 2022
- Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis. · BMC pulmonary medicine · 2021
- Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan. · Respiratory investigation · 2021
- Negative impact of anorexia and weight loss during prior pirfenidone administration on subsequent nintedanib treatment in patients with idiopathic pulmonary fibrosis. · BMC pulmonary medicine · 2019
- Japanese guideline for the treatment of idiopathic pulmonary fibrosis. · Respiratory investigation · 2018
- [The Latest Information on Respiratory Disease Management. Topics: III. New Treatment of Idiopathic Pulmonary Fibrosis]. · Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine · 2016
- Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis. · The European respiratory journal · 2015
Medical disclaimer. Research listings are for information only and are not medical advice.